VIATRIS INC. Long-term Debt, Gross
VIATRIS INC. (VTRS) had Long-term Debt, Gross of $12.94 billion as of 2025-12-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-08-06
- 2025-12-31: Long-term Debt, Gross $12.94B; Long-term Debt, Gross as first filed $13.98B.
- 2024-12-31: Long-term Debt, Gross $13.99B; Long-term Debt, Gross as first filed $13.58B.
- 2023-12-31: Long-term Debt, Gross $15.27B; Long-term Debt, Gross as first filed $17.61B.
- 2022-12-31: Long-term Debt, Gross $17.86B; Long-term Debt, Gross as first filed $18.71B.
| Period end | Long-term Debt, Gross | Long-term Debt, Gross as first filed |
|---|---|---|
| 2025-12-31 | $12.94B 10-Q · filed 2026-08-06 | $13.98B 10-K · filed 2026-02-26 |
| 2024-12-31 | $13.99B 10-Q · filed 2025-11-06 | $13.58B 10-K · filed 2025-02-27 |
| 2023-12-31 | $15.27B 10-Q · filed 2024-11-07 | $17.61B 10-K · filed 2024-02-28 |
| 2022-12-31 | $17.86B 10-Q · filed 2023-11-08 | $18.71B 10-K · filed 2023-02-27 |
| 2021-12-31 | $18.92B 10-Q · filed 2022-11-07 | $20.95B 10-K · filed 2022-02-28 |
| 2020-12-31 | $21.09B 10-Q · filed 2021-11-08 | $23.95B 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |